Abstract A novel gene has been characterized, designated C16orf5, with an unusually high content of proline residues (40% over 104 residues) at the N-terminus of the protein.
Introduction
Balanced chromosome translocations occur in humans with a frequency of approximately 1 in 800 individuals and are usually associated with a normal clinical phenotype. However, de novo translocations are associated with an increased risk of clinical abnormalities (Warburton 1991) , which can arise from the disruption of genes at the translocation breakpoints. An extensive somatic cell mouse/human hybrid panel has been constructed (Callen et al. 1995) . Included in this panel is the hybrid CY196, which is derived from a de novo translocation ascertained in a patient with epilepsy and mental retardation.
An EST WI-16589 was mapped on the GB4 radiation hybrid panel at 16p13.3 (http://www.ncbi.nlm.nih.gov/ genemap98) and also has been located in the adjacent distal interval to the somatic hybrid breakpoint CY196 (Callen et al. 1989) . Because this gene was highly expressed in the brain, this was a candidate for disruption by the CY196 breakpoint.
Materials and methods
Sequence of the cDNA was generated by amplification of cDNA clone inserts and sequencing with an ABI 377 sequencer using standard techniques. The 5Ј-end of the gene was confirmed by 5Ј-RACE (rapid amplification of cDNA end) on poly A ϩ mRNA from fetal brain tissue. The following nested gene-specific primers were used to generate 5Ј-RACE (Gibco BRL, Life Technologies, Gaithersburg, USA) products, which were then sequenced: GSP#1 (nt 346-362) 5Ј-CCT TTC TCT TCC AGA AG, GSP#2 (nt 290-308) 5Ј-CTC GCT GGA CAT CTT CGC TG, and GSP#3 (nt 277-296) 5Ј-TTC GCT GCT TCT CCT CAA AT.
To map the gene relative to the CY196 breakpoint, cDNA probes were used to screen two different PAC libraries (Genome Systems, St. Louis, Missouri, and PAC/ BAC Resources, Buffalo, New York) each with a threefold coverage of the human genome. Positive clones were purchased and inserts sized and restriction mapped using pulsed-field gel electrophoresis (PFGE) and the infrequently cutting restriction enzymes NotI and EagI. This method allowed determination of clone overlaps. A further walk was undertaken from one of the furthest extending PACs by screening a BAC library (Genome Systems) with the cloned SP6 end fragment of the insert.
To determine the partial genomic structure of the gene DNA was prepared from a PAC, shown to contain the gene, using a plasmid kit (Qiagen, Hilden, Germany) and digested separately with the blunt end-cutting restriction enzymes AluI, RsaI, ScaI, HaeIII, and PvuII for ligation to bubble linkers (Gecz et al. 1999) . Tentative exonic boundaries were generated by PCR using gene-specific primers and bubble linker-specific primers. The resulting PCR products were purified and then directly sequenced using dye terminator fluorescence chemistry (ABI-Perkin Elmer, Warrington, UK) and the original PCR primers. Sequencing reactions were run on an ABI377 sequencer and analyzed using the Laser Gene DNA software package (DNAstar, Madison, USA). Further analysis utilized the PROSITE database (Hofmann et al. 1999 ) and PSORTII (Nakai and Horton 1999) . Expression of the C16orf5 transcript was evaluated using a Multiple Tissue Northern and RNA Master Blot (Clontech, Palo Alto, USA). The blots were probed with the insert of cDNA clone AA070715 as per manufacturer's protocol.
Chromosomal assignment of the human C16orf5 was performed by fluorescence in situ hybridization (FISH). The cDNAs AA070715 and H07909 were nick-translated with biotin-14-ATP and hybridized in situ at a final concentration of 20 ng/µl to metaphase chromosomes from a normal male. The FISH method was modified from that previously described (Callen et al. 1990 ). Chromosomes were stained before analysis with both propidium iodide (as counterstain) and DAPI (for chromosome identification). Images of metaphase preparation were captured by a cooled CCD camera using the CytoVision Ultra Image collection and enhancement system (Applied Imaging, New Castle, UK). Twenty metaphases from a normal male were examined for the fluorescence signal.
Results and discussion
A BLAST search of the dbEST database with the sequence of W1-16589 identified two overlapping cDNA clones, AA070715 and H07909 (Fig. 2B) . End sequences for both these clones were available, which enabled design of primers to generate the complete cDNA sequence. This sequence, together with a further 193 bp generated by 5Ј-RACE, is presented in Fig. 1B . The gene C16orf5 (GenBank accession number, AF131218) consists of an open reading frame of 786 bp, encoding a putative protein of 261 amino acids and a large 1517-bp 3Ј-untranslated region. The putative translation initiation site begins with an ATG at the nucleotide 298, and the sequence surrounding the site conforms to Kozak's rule (Kozak 1991 (Kozak , 1996 . Two polyadenylation sites are present, one at 2144 bp and the second at 2756 bp.
The Northern blot showed a single band approximately 2.4 kb in size with the strongest signal in brain but also expression in heart, skeletal muscle, kidney, pancreas, and liver (Fig. 1A) . This is likely to correspond to transcripts that are generated using the polyadenylation site starting at 2,144 bp. Although some transcripts in the NCBI database dBEST were generated using the second polyadenylation site starting at 2,756 bp, there was no clear evidence of transcripts of this size from the Northern blot. Also probed was a RNA dot blot that contained poly A ϩ RNAs from 50 different human tissues with the quantity of RNA normalized with respect to several housekeeping genes. This procedure showed that there was expression in all the brain samples (whole brain, amygdala, caudate nucleus, cerebellum, cerebral cortex, frontal lobe, hippocampus, medulla oblongata, occipital lobe, putamen, substantia nigra, temporal lobe, thalamus, subthalamic nucleus, and spinal cord), while heart and all other tissues showed very weak or absent expression (data not shown). The expression patterns determined from the normalized RNA of the dot blot therefore show a brain-restricted expression, suggesting that the C16orf5 gene has some brain-specific function.
Database searching using the entire C16orf5 cDNA sequence showed no significant homology to known proteins and domains. Searching of the PROSITE database with the C16orf5 protein sequence predicted a single N-glycosylation site, three N-myristoylation sites, and two protein kinase C phosphorylation sites, which suggested that the protein might encode a secreted or plasma membrane protein (Habuchi et al. 1998) . The notable features of the peptide include its proline richness (40% over 104 residues) at the N-terminus of the protein. Proline richness is a characteristic of DNA binding proteins (Bennet and Reed 1993) . Proline-rich activation domains are associated with transcription factors like CTF/NF-1, AP-2, and steroid receptors for progesterone and estrogen (Mermod et al. 1989 ). The predicted C16orf5 protein is also cysteine rich in the Cterminal half of the gene, with 14 cysteine residues present that may participate in intra-and/or interchain disulfide bonding (Marquardt et al. 1998) . Computer prediction of the subcellular localization using PSORT II indicated that C16orf5 would most probably localize to the nucleus.
The location of the C16orf5 gene was confirmed by FISH analysis of metaphase chromosomes. Twenty metaphases all showed signal on one or both chromatids of chromosome 16 at 16p13.3 for the cDNA probes H07907 and AA070715. 3 and 5 nonspecific dots were observed in these 20 metaphases respectively. The gene was further localized by Southern analysis of a human/rodent somatic cell hybrid panel (Callen et al. 1989) . PstI-and HindIII-digested somatic cell hybrid DNA was blotted and hybridized with the inserts of cDNA clones (data not shown). Results of FISH and Southern analysis localized the gene to chromosome 16p13.3 between the somatic cell hybrid breakpoints 23HA and CY196 ( Fig. 2A, B) . (Sheets et al. 1990; Wahle and Keller 1992) , and an in-frame stop codon before the initiation codon are underlined; proline residues are boxed and cysteine residues are shown in boldface. The predicted 1N-glycosylation (ASN), 3N-myristoylation (MYRISTYL), and two protein kinase C (PKC) phosphorylation sites are indicated. Each exon boundary is shown by ϾϽ above the nucleotide sequence. The nucleotide sequence reported here will appear in GenBank under the accession number AF131218 Localization of C16orf5 relative to the CY196 breakpoint was achieved by constructing a PAC and BAC contig containing the entire gene (Fig. 2B) . Genomic sequencing enabled the determination of four exon-intron boundaries ( Fig. 1B ; sequence available on request). Hence, the gene C16orf5 consists of at least four exons. The genomic size of C16orf5 was estimated to be 10 kb by hybridizing Southern blots of PstI-digested genomic DNA with cDNA clones AA070715 and H07909.
The contig containing the C16orf5 transcript was orientated by hybridizing to a YAC spanning this region (data not shown). This result demonstrated that the C16orf5 gene has its 3Ј-end more distally located and is entirely contained within a region of this contig, which maps distal to the somatic cell hybrid breakpoint CY196. Therefore, the translocation breakpoint represented in CY196 does not disrupt this gene. Although the function of the C16orf5 protein is unknown, its proline richness, presence of cysteine residues, predicted nuclear localization, and abundant brain-specific expression suggest that it is likely to have an important role in the development and function of neuronal cells.
